NYSEAMERICAN:TRXC

TransEnterix - TRXC Stock Forecast, Price & News

$0.61

-0.04 (-6.13%)

(As of 03/27/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.61
▼
$0.64
50-Day Range: N/A
52-Week Range: $0.28
▼
$6.95

Volume: 664,819 shs
Average Volume: 44.56 million shs
Market Capitalization: $87.42 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

About TransEnterix (NYSEAMERICAN:TRXC) Stock

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.

Receive TRXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TransEnterix and its competitors with MarketBeat's FREE daily newsletter.

TRXC Stock News Headlines

February 26, 2023 | msn.com

Liberia - Two Ex-Soldiers Claim Massaquoi Was At Waterside, Ordered Killings, Rapes

October 18, 2022 | streetinsider.com

Asensus Surgical, Inc. To Present at The LD Micro Main Event XV - StreetInsider.com

March 29, 2023 | The Oxford Club (Ad)

My No. 1 dividend stock for a LIFETIME of income.

Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.

September 24, 2022 | seekingalpha.com

ASXC Asensus Surgical, Inc.

September 21, 2022 | finance.yahoo.com

Orthopedic Surgical Robots Market is likely to Grow USD 24.22 Billion with Registering a CAGR of 18.1% by 2029, Size, Share, Growth, Emerging Trends, and Regional Overview - Yahoo Finance

September 21, 2022 | globenewswire.com

Orthopedic Surgical Robots Market is likely to Grow USD 24.22 Billion with Registering a CAGR of 18.1% by 2029, Size, Share, Growth, Emerging Trends, and Regional Overview - GlobeNewswire

September 2, 2022 | benzinga.com

With 17.40% CAGR, Surgical Robots Market Size to Worth US$ 26.69 billion by 2030 | Growth Plus Reports - Benzinga

August 16, 2022 | finance.yahoo.com

Spine Surgery Robots Market is Set to Exceed Valuation of USD 139.93 Million with Potential Growth Rate of 8.40% by 2029 | Analyzed by Size Share, Trends, Key Players & Future Growth Outlook - Yahoo Finance

March 29, 2023 | Weiss Ratings (Ad)

Banking Nightmare

During and after the Great Financial Crisis of 2008, 485 U.S. banks went under. Here at Weiss Ratings, we warned about 484 — an accuracy rate of 99.8%. Now, we have a new warning. But this time, it's not just about a few hundred banks … it's about nearly every single bank in America …

August 9, 2022 | streetinsider.com

Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2022 - StreetInsider.com

June 13, 2022 | globenewswire.com

Collaborative Robots Market worth $1671 Million by 2028 with a CAGR of 15.2% - GlobeNewswire

April 14, 2022 | finance.yahoo.com

Bariatric Surgical Devices Market size worth $ 2223.84 Million, Globally, by 2028 at 9.29% CAGR: Verified Market Research® - Yahoo Finance

February 17, 2022 | finance.yahoo.com

Robotic Surgery Services Global Market Report 2022 - Yahoo Finance

February 15, 2022 | finance.yahoo.com

Surgical Robots Market Size & Share Report [2021-2026] | Market worth USD 6,875.1 Mn with 21.4% CAGR - Yahoo Finance

February 11, 2022 | businesswire.com

Global Medical Device Market Outlook 2022-2027: Demographic Drivers, Cultural Shifts and the Pandemic have Supercharged the Medical Device Market - ResearchAndMarkets.com - Business Wire

October 26, 2021 | finance.yahoo.com

Here's Why TransEnterix Rallied 47% in 2017

October 9, 2021 | fool.com

Is Intuitive Surgical a Buy on the Dip? - Motley Fool

August 13, 2021 | finance.yahoo.com

Alpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of Directors - Yahoo Finance

August 4, 2021 | globenewswire.com

Medical Robots Market Research Report 2021 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast - GlobeNewswire

August 4, 2021 | finance.yahoo.com

Medical Robots Market Research Report 2021 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast - Yahoo Finance

July 9, 2021 | businesswire.com

Worldwide Surgical Robots Industry to 2026 - Featuring Accuray Incorporated, CMR Surgical and Medtronic Among Others - ResearchAndMarkets.com - Business Wire

June 29, 2021 | finance.yahoo.com

Global Genitourinary Robotic Surgery Market-Forecast to 2026 - Yahoo Finance

June 29, 2021 | globenewswire.com

Global Genitourinary Robotic Surgery Market-Forecast to 2026 - GlobeNewswire

June 8, 2021 | investorplace.com

Asensus Surgical Stock Is Coiling for the Next Move Higher - Investorplace.com

June 1, 2021 | nasdaq.com

Asensus Surgical Investors Need To Take Long-Term View on Its Technology - Nasdaq

June 1, 2021 | seekingalpha.com

Asensus Surgical: Digging In Against Incumbents In The Robotic Surgery Field - Seeking Alpha

May 31, 2021 | investorplace.com

Asensus Surgical Investors Need To Take Long-Term View on Its Technology - Investorplace.com

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive TRXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TransEnterix and its competitors with MarketBeat's FREE daily newsletter.

TRXC Company Calendar

Last Earnings: 11/05/2020
Today: 3/29/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSEAMERICAN
Industry: Surgical & Medical Instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSEAMERICAN:TRXC
CUSIP: N/A
CIK: 876378
Web: www.transenterix.com
Phone: +1-919-7658400
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($4.22)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-154,200,000.00
Net Margins: -2,149.15%
Pretax Margin: N/A
Return on Equity: -83.74%
Return on Assets: -64.94%

Debt

Debt-to-Equity Ratio: 0.04
Current Ratio: 3.24
Quick Ratio: 2.30

Sales & Book Value

Annual Sales: $8.53 million
Price / Sales: 10.25
Cash Flow: $0.44 per share
Price / Cash Flow: 1.40
Book Value: $2.68 per share
Price / Book: 0.23

Miscellaneous

Outstanding Shares: 142,777,000
Free Float: N/A
Market Cap: $87.42 million
Optionable: Optionable
Beta: 2.56

Key Executives

Mr. Todd M. Pope (Age 53)
CEO, Pres & Director

Mr. Joseph P. Slattery (Age 53)
Exec. VP, CFO & Principal Accounting Officer

Mr. Anthony Fernando (Age 46)
COO, CTO & Exec. VP

Mr. Joshua B. Weingard (Age 45)
Chief Legal Officer & Sec.

Dr. Stephanie M. Fitts Ph.D. (Age 52)
VP of RA/QA, Clinical and Compliance

Key Competitors

View All Competitors

TRXC Stock - Frequently Asked Questions

How were TransEnterix's earnings last quarter?: TransEnterix, Inc. (NYSEAMERICAN:TRXC) issued its quarterly earnings results on Thursday, November, 5th. The medical instruments supplier reported ($0.12) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.11. The medical instruments supplier earned $0.81 million during the quarter, compared to analysts' expectations of $0.73 million. TransEnterix had a negative net margin of 2,149.15% and a negative trailing twelve-month return on equity of 83.74%.
What other stocks do shareholders of TransEnterix own?: Based on aggregate information from My MarketBeat watchlists, some companies that other TransEnterix investors own include Oramed Pharmaceuticals (ORMP), Compugen (CGEN), Editas Medicine (EDIT), Ekso Bionics (EKSO), Actinium Pharmaceuticals (ATNM), XOMA (XOMA), Geron (GERN), OPKO Health (OPK), NVIDIA (NVDA) and Advanced Micro Devices (AMD).
What is TransEnterix's stock symbol?: TransEnterix trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "TRXC."

How do I buy shares of TransEnterix?: Shares of TRXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is TransEnterix's stock price today?: One share of TRXC stock can currently be purchased for approximately $0.61.
How much money does TransEnterix make?: TransEnterix (NYSEAMERICAN:TRXC) has a market capitalization of $87.42 million and generates $8.53 million in revenue each year. The medical instruments supplier earns $-154,200,000.00 in net income (profit) each year or ($4.22) on an earnings per share basis.
How can I contact TransEnterix?: TransEnterix's mailing address is 635 Davis Dr Ste 300, MORRISVILLE, NC 27560-7199, United States. The official website for the company is www.transenterix.com. The medical instruments supplier can be reached via phone at +1-919-7658400 or via email at invest@transenterix.com.

This page (NYSEAMERICAN:TRXC) was last updated on 3/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial